The DOI matches its Crossref record; 145 of the 145 references it cites were found in a registry or an index.
Apoptosis-based therapies and drug targets
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
Targan, S. R., Hanauer, S. B., van Deventer, S. J. H., Mayer, L., Present, D. H., Braakman, T., DeWoody, K. L., Schaible, T. F., & Rutgeerts, P. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710093371502 · Cited by 3,135
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., & Korsmeyer, S. J. (1995) · Cell · doi:10.1016/0092-8674(95)90411-5 · Cited by 2,100
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756
Letai, A., Bassik, M. C., Walensky, L. D., Sorcinelli, M. D., Weiler, S., & Korsmeyer, S. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00127-7 · Cited by 1,677
The Bcl-2 family: roles in cell survival and oncogenesis
Cory, S., Huang, D. C. S., & Adams, J. M. (2003) · Oncogene · doi:10.1038/sj.onc.1207102 · Cited by 1,463
Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270
Wang, J.-L., Liu, D., Zhang, Z.-J., Shan, S., Han, X., Srinivasula, S. M., Croce, C. M., Alnemri, E. S., & Huang, Z. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7124 · Cited by 1,201
Khuri, F. R., Nemunaitis, J., Ganly, I., Arseneau, J., Tannock, I. F., Romel, L., Gore, M., Ironside, J., MacDougall, R. H., Heise, C., et al. (2000) · Nature Medicine · doi:10.1038/78638 · Cited by 1,101
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
Bykov, V. J. N., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Bergman, J., Wiman, K. G., & Selivanova, G. (2002) · Nature Medicine · doi:10.1038/nm0302-282 · Cited by 1,067
Many cuts to ruin: a comprehensive update of caspase substrates
Fischer, U., Jänicke, R. U., & Schulze-Osthoff, K. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401160 · Cited by 1,029
Self-citationInhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.-H., Tschopp, J., & French, L. E. (1998) · Science · doi:10.1126/science.282.5388.490 · Cited by 1,005
Yang, Y., Fang, S., Jensen, J. P., Weissman, A. M., & Ashwell, J. D. (2000) · Science · doi:10.1126/science.288.5467.874 · Cited by 988
Apoptosis signaling by death receptors
Schulze‐Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., & Peter, M. E. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2540439.x · Cited by 978
Self-citationUren (2000) · Molecular Cell · Cited by 965
The protein structures that shape caspase activity, specificity, activation and inhibition
FUENTES-PRIOR, P., & SALVESEN, G. S. (2004) · Biochemical Journal · doi:10.1042/bj20041142 · Cited by 880
Structural basis of IAP recognition by Smac/DIABLO
Wu, G., Chai, J., Suber, T. L., Wu, J.-W., Du, C., Wang, X., & Shi, Y. (2000) · Nature · doi:10.1038/35050012 · Cited by 861
Jo, M., Kim, T.-H., Seol, D.-W., Esplen, J. E., Dorko, K., Billiar, T. R., & Strom, S. C. (2000) · Nature Medicine · doi:10.1038/75045 · Cited by 843
Pharmacological Rescue of Mutant p53 Conformation and Function
Foster, B. A., Coffey, H. A., Morin, M. J., & Rastinejad, F. (1999) · Science · doi:10.1126/science.286.5449.2507 · Cited by 799
Structural Basis for the Inhibition of Caspase-3 by XIAP
Riedl, S. J., Renatus, M., Schwarzenbacher, R., Zhou, Q., Sun, C., Fesik, S. W., Liddington, R. C., & Salvesen, G. S. (2001) · Cell · doi:10.1016/s0092-8674(01)00274-4 · Cited by 792
Deveraux, Q. L. (1999) · The EMBO Journal · doi:10.1093/emboj/18.19.5242 · Cited by 751
Fulda, S., Wick, W., Weller, M., & Debatin, K.-M. (2002) · Nature Medicine · doi:10.1038/nm735 · Cited by 741
Puthalakath, H., & Strasser, A. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400998 · Cited by 722
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
Lawrence, D., Shahrokh, Z., Marsters, S., Achilles, K., Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Schow, P., et al. (2001) · Nature Medicine · doi:10.1038/86397 · Cited by 702
A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death
Li, L., Thomas, R. M., Suzuki, H., De Brabander, J. K., Wang, X., & Harran, P. G. (2004) · Science · doi:10.1126/science.1098231 · Cited by 656
Attenuation of Ischemia/Reperfusion Injury in Rats by a Caspase Inhibitor
Yaoita, H., Ogawa, K., Maehara, K., & Maruyama, Y. (1998) · Circulation · doi:10.1161/01.cir.97.3.276 · Cited by 626
Identification of small-molecule inhibitors of interaction between the BH3 domain and Bcl-xL
Degterev, A., Lugovskoy, A., Cardone, M., Mulley, B., Wagner, G., Mitchison, T., & Yuan, J. (2001) · Nature Cell Biology · doi:10.1038/35055085 · Cited by 550
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
Ichikawa, K., Liu, W., Zhao, L., Wang, Z., Liu, D., Ohtsuka, T., Zhang, H., Mountz, J. D., Koopman, W. J., Kimberly, R. P., et al. (2001) · Nature Medicine · doi:10.1038/91000 · Cited by 543
Uren, A. G., Wong, L., Pakusch, M., Fowler, K. J., Burrows, F. J., Vaux, D. L., & Choo, K. H. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00769-7 · Cited by 527
Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte
Hotchkiss, R. S., Chang, K. C., Swanson, P. E., Tinsley, K. W., Hui, J. J., Klender, P., Xanthoudakis, S., Roy, S., Black, C., Grimm, E., et al. (2000) · Nature Immunology · doi:10.1038/82741 · Cited by 526
Structural Basis of Caspase Inhibition by XIAP
Huang, Y., Park, Y. C., Rich, R. L., Segal, D., Myszka, D. G., & Wu, H. (2001) · Cell · doi:10.1016/s0092-8674(01)00273-2 · Cited by 467
Prevention of lymphocyte cell death in sepsis improves survival in mice
Hotchkiss, R. S., Tinsley, K. W., Swanson, P. E., Chang, K. C., Cobb, J. P., Buchman, T. G., Korsmeyer, S. J., & Karl, I. E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14541 · Cited by 454
Sandborn, W. J., & Hanauer, S. B. (1999) · Inflammatory Bowel Diseases · doi:10.1097/00054725-199905000-00008 · Cited by 454
Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3
Tzung, S.-P., Kim, K. M., Basañez, G., Giedt, C. D., Simon, J., Zimmerberg, J., Zhang, K. Y. J., & Hockenbery, D. M. (2001) · Nature Cell Biology · doi:10.1038/35055095 · Cited by 452
RGD peptides induce apoptosis by direct caspase-3 activation
Buckley, C. D., Pilling, D., Henriquez, N. V., Parsonage, G., Threlfall, K., Scheel-Toellner, D., Simmons, D. L., Akbar, A. N., Lord, J. M., & Salmon, M. (1999) · Nature · doi:10.1038/17409 · Cited by 432
Curnis, F., Sacchi, A., Borgna, L., Magni, F., Gasparri, A., & Corti, A. (2000) · Nature Biotechnology · doi:10.1038/81183 · Cited by 419
ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas
Vucic, D., Stennicke, H. R., Pisabarro, M. T., Salvesen, G. S., & Dixit, V. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00781-8 · Cited by 414
Predominant pathogenic role of tumor necrosis factor in experimental colitis in mice
Neurath, M. F., Fuss, I., Pasparakis, M., Alexopoulou, L., Haralambous, S., Meyer zum Büschenfelde, K., Strober, W., & Kollias, G. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270722 · Cited by 413
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity
Schimmer, A. D., Welsh, K., Pinilla, C., Wang, Z., Krajewska, M., Bonneau, M.-J., Pedersen, I. M., Kitada, S., Scott, F. L., Bailly-Maitre, B., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00332-5 · Cited by 411
Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties
Caserta, T. M., Smith, A. N., Gultice, A. D., Reedy, M. A., & Brown, T. L. (2003) · Apoptosis · doi:10.1023/a:1024116916932 · Cited by 403
Distinctive Roles of PHAP Proteins and Prothymosin-α in a Death Regulatory Pathway
Jiang, X., Kim, H.-E., Shu, H., Zhao, Y., Zhang, H., Kofron, J., Donnelly, J., Burns, D., Ng, S.-C., Rosenberg, S., et al. (2003) · Science · doi:10.1126/science.1076807 · Cited by 378
Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury
Springer, J. E., Azbill, R. D., & Knapp, P. E. (1999) · Nature Medicine · doi:10.1038/11387 · Cited by 371
Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer
Oost, T. K., Sun, C., Armstrong, R. C., Al-Assaad, A.-S., Betz, S. F., Deckwerth, T. L., Ding, H., Elmore, S. W., Meadows, R. P., Olejniczak, E. T., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040037k · Cited by 366
Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death
D'Souza, S. D., Bonetti, B., Balasingam, V., Cashman, N. R., Barker, P. A., Troutt, A. B., Raine, C. S., & Antel, J. P. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.6.2361 · Cited by 354
Rothmann, T., Hengstermann, A., Whitaker, N. J., Scheffner, M., & zur Hausen, H. (1998) · Journal of Virology · doi:10.1128/jvi.72.12.9470-9478.1998 · Cited by 353
Selivanova, G., Iotsova, V., Okan, I., Fritsche, M., Ström, M., Groner, B., Grafström, R. C., & Wiman, K. G. (1997) · Nature Medicine · doi:10.1038/nm0697-632 · Cited by 343
Nikolovska-Coleska, Z., Xu, L., Hu, Z., Tomita, Y., Li, P., Roller, P. P., Wang, R., Fang, X., Guo, R., Zhang, M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030420+ · Cited by 343
Cancer gene therapy using a survivin mutant adenovirus
Mesri, M., Wall, N. R., Li, J., Kim, R. W., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12983 · Cited by 337
Discovery of Small-Molecule Inhibitors of Bcl-2 through Structure-Based Computer Screening
Enyedy, I. J., Ling, Y., Nacro, K., Tomita, Y., Wu, X., Cao, Y., Guo, R., Li, B., Zhu, X., Huang, Y., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010016f · Cited by 315
Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)
Nitsch, R., Bechmann, I., Deisz, R. A., Haas, D., Lehmann, T. N., Wendling, U., & Zipp, F. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02659-3 · Cited by 300
Non‐specific effects of methyl ketone peptide inhibitors of caspases
Schotte, P., Declercq, W., Van Huffel, S., Vandenabeele, P., & Beyaert, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01640-8 · Cited by 300
Reed, J. C., Stein, C. A., Subasinghe, C., Haldar, S., Croce, C. M., Yum, S., & Cohen, J. S. (1990) · PubMed · Cited by 289
Sandborn, W. J., Hanauer, S., Loftus, E. V., Tremaine, W. J., Kane, S., Cohen, R., Hanson, K., Johnson, T., Schmitt, D., & Jeche, R. (2004) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.40462.x · Cited by 276
Chalcone Derivatives Antagonize Interactions between the Human Oncoprotein MDM2 and p53
Stoll, R., Renner, C., Hansen, S., Palme, S., Klein, C., Belling, A., Zeslawski, W., Kamionka, M., Rehm, T., Mühlhahn, P., et al. (2001) · Biochemistry · doi:10.1021/bi000930v · Cited by 275
Elevated expression of inhibitor of apoptosis proteins in prostate cancer.
Krajewska, M., Krajewski, S., Banares, S., Huang, X., Turner, B., Bubendorf, L., Kallioniemi, O., Shabaik, A. S., Vitiello, A., Peehl, D. M., et al. (2003) · PubMed · Cited by 275
Rodriguez, I., Matsuura, K., Ody, C., Nagata, S., & Vassalli, P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.2067 · Cited by 269
Friedler, A., Hansson, L. O., Veprintsev, D. B., Freund, S. M. V., Rippin, T. M., Nikolova, P. V., Proctor, M. R., Rüdiger, S., & Fersht, A. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241629998 · Cited by 268
Yang, L., Mashima, T., Sato, S., Mochizuki, M., Sakamoto, H., Yamori, T., Oh‐hara, T., & Tsuruo, T. (2003) · PubMed · Cited by 266
Arnt, C. R., Chiorean, M. V., Heldebrant, M. P., Gores, G. J., & Kaufmann, S. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207578200 · Cited by 263
Holcik, M., Yeh, C., Korneluk, R. G., & Chow, T. (2000) · Oncogene · doi:10.1038/sj.onc.1203765 · Cited by 259
Holinger, E. P., Chittenden, T., & Lutz, R. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.19.13298 · Cited by 254
NMR Structure and Mutagenesis of the Third Bir Domain of the Inhibitor of Apoptosis Protein XIAP
Sun, C., Cai, M., Meadows, R. P., Xu, N., Gunasekera, A. H., Herrmann, J., Wu, J. C., & Fesik, S. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006226200 · Cited by 254
García-Echeverría, C., Chène, P., Blommers, M. J. J., & Furet, P. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990966p · Cited by 246
Butz, K., Denk, C., Ullmann, A., Scheffner, M., & Hoppe-Seyler, F. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.110538897 · Cited by 241
Discovery, characterization and SAR of gambogic acid as a potent apoptosis inducer by a HTS assay
Zhang, H.-Z., Kasibhatla, S., Wang, Y., Herich, J., Guastella, J., Tseng, B., Drewe, J., & Cai, S. X. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2003.11.013 · Cited by 239
Lee, D., Long, S. A., Adams, J. L., Chan, G., Vaidya, K. S., Francis, T. A., Kikly, K., Winkler, J. D., Sung, C.-M., Debouck, C., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.16007 · Cited by 234
Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein
Vocero-Akbani, A. M., Heyden, N. V., Lissy, N. A., Ratner, L., & Dowdy, S. F. (1999) · Nature Medicine · doi:10.1038/4710 · Cited by 220
Hu, Y., Cherton-Horvat, G., Dragowska, V., Baird, S. D., Korneluk, R. G., Durkin, J. P., Mayer, L. D., & LaCasse, E. C. (2003) · PubMed · Cited by 220
Hattori, K., Hirano, T., Miyajima, H., Yamakawa, N., Tateno, M., Oshimi, K., Kayagaki, N., Yagita, H., & Okumura, K. (1998) · Blood · doi:10.1182/blood.v91.11.4051 · Cited by 217
Neutralization of CD95 ligand promotes regeneration and functional recovery after spinal cord injury
Demjen, D., Klussmann, S., Kleber, S., Zuliani, C., Stieltjes, B., Metzger, C., Hirt, U. A., Walczak, H., Falk, W., Essig, M., et al. (2004) · Nature Medicine · doi:10.1038/nm1007 · Cited by 217
The Caspase Inhibitor IDN-6556 Attenuates Hepatic Injury and Fibrosis in the Bile Duct Ligated Mouse
Canbay, A., Feldstein, A., Baskin-Bey, E., Bronk, S. F., & Gores, G. J. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060129 · Cited by 215
Imoto, I., Yang, Z.-Q., Pimkhaokham, A., Tsuda, H., Shimada, Y., Imamura, M., Ohki, M., & Inazawa, J. (2001) · PubMed · Cited by 213
Expression and Genetic Analysis of XIAP-Associated Factor 1 (XAF1) in Cancer Cell Lines
Fong, W. G., Liston, P., Rajcan-Separovic, E., St. Jean, M., Craig, C., & Korneluk, R. G. (2000) · Genomics · doi:10.1006/geno.2000.6364 · Cited by 213
Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke
Martin-Villalba, A., Hahne, M., Kleber, S., Vogel, J., Falk, W., Schenkel, J., & Krammer, P. H. (2001) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400882 · Cited by 209
Roth, W., Isenmann, S., Naumann, U., Kügler, S., Bähr, M., Dichgans, J., Ashkenazi, A., & Weller, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1693 · Cited by 208
In situ assembly of enzyme inhibitors using extended tethering
Erlanson, D. A., Lam, J. W., Wiesmann, C., Luong, T. N., Simmons, R. L., DeLano, W. L., Choong, I. C., Burdett, M. T., Flanagan, W. M., Lee, D., et al. (2003) · Nature Biotechnology · doi:10.1038/nbt786 · Cited by 203
The kiss of death: promises and failures of death receptors and ligands in cancer therapy
Daniel, P., Wieder, T., Sturm, I., & Schulze-Osthoff, K. (2001) · Leukemia · doi:10.1038/sj.leu.2402169 · Cited by 198
Self-citationTaylor, J. K., Zhang, Q. Q., Wyatt, J. R., & Dean, N. M. (1999) · Nature Biotechnology · doi:10.1038/15079 · Cited by 197
Rozman-Pungerčar, J., Kopitar-Jerala, N., Bogyo, M., Turk, D., Vasiljeva, O., Štefe, I., Vandenabeele, P., Brömme, D., Puizdar, V, Fonović, M., et al. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401247 · Cited by 197
Baens, M., Maes, B., Steyls, A., Geboes, K., Marynen, P., & De Wolf-Peeters, C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65012-2 · Cited by 196
Synthetic activation of caspases: Artificial death switches
MacCorkle, R. A., Freeman, K. W., & Spencer, D. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3655 · Cited by 186
Maintenance of caspase-3 proenzyme dormancy by an intrinsic “safety catch” regulatory tripeptide
Roy, S., Bayly, C. I., Gareau, Y., Houtzager, V. M., Kargman, S., Keen, S. L. C., Rowland, K., Seiden, I. M., Thornberry, N. A., & Nicholson, D. W. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111085198 · Cited by 183
Geldanamycin selectively destabilizes and conformationally alters mutated p53.
Blagosklonny, M. V., Toretsky, J. A., & Neckers, L. (1995) · PubMed · Cited by 178
Han, B. H., Xu, D., Choi, J., Han, Y., Xanthoudakis, S., Roy, S., Tam, J., Vaillancourt, J., Colucci, J., Siman, R., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202931200 · Cited by 178
McManus, D. C., Lefebvre, C. A., Cherton-Horvat, G., St-Jean, M., Kandimalla, E. R., Agrawal, S., Morris, S. J., Durkin, J. P., & LaCasse, E. C. (2004) · Oncogene · doi:10.1038/sj.onc.1207967 · Cited by 170
Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells.
Wang, J., Zhang, Z. J., Choksi, S., Shan, S., Lu, Z., Croce, C. M., Alnemri, E. S., Korngold, R., & Huang, Z. (2000) · PubMed · Cited by 167
Tamm, I., Richter, S., Oltersdorf, D., Creutzig, U., Harbott, J., Scholz, F., Karawajew, L., Ludwig, W.-D., & Wuchter, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0642 · Cited by 165
Campos, L., Sabido, O., Rouault, J., & Guyotat, D. (1994) · Blood · doi:10.1182/blood.v84.2.595.595 · Cited by 164
Guo, F., Nimmanapalli, R., Paranawithana, S., Wittman, S., Griffin, D., Bali, P., O'Bryan, E., Fumero, C., Wang, H. G., & Bhalla, K. (2002) · Blood · doi:10.1182/blood.v99.9.3419 · Cited by 162
Identification of Chelerythrine as an Inhibitor of BclXL Function
Chan, S.-L., Lee, M. C., Tan, K. O., Yang, L.-K., Lee, A. S. Y., Flotow, H., Fu, N. Y., Butler, M. S., Soejarto, D. D., Buss, A. D., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300138200 · Cited by 162
Komata, T., Kondo, Y., Kanzawa, T., Hirohata, S., Koga, S., Sumiyoshi, H., Srinivasula, S. M., Barna, B. P., Germano, I. M., Takakura, M., et al. (2001) · PubMed · Cited by 156
Reed, J. C., Cuddy, M., Haldar, S., Croce, C. M., Nowell̀, P. C., Makover, D., & Bradley, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3660 · Cited by 154
Sandborn, W. J., Feagan, B. G., Radford‐Smith, G. L., Kovacs, A., Enns, R., Innes, A., & Patel, J. (2004) · Gut · doi:10.1136/gut.2003.035253 · Cited by 154
Caspase Inhibitors Reduce Neuronal Injury After Focal but Not Global Cerebral Ischemia in Rats
Li, H., Colbourne, F., Sun, P., Zhao, Z., & Buchan, A. M. (2000) · Stroke · doi:10.1161/01.str.31.1.176 · Cited by 152
BIRinging Chromosomes through Cell Division—And Survivin' the Experience
Reed, J. C., & Bischoff, J. R. (2000) · Cell · doi:10.1016/s0092-8674(00)00076-3 · Cited by 151
Silke, J., Hawkins, C. J., Ekert, P. G., Chew, J., Day, C. L., Pakusch, M., Verhagen, A. M., & Vaux, D. L. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200108085 · Cited by 147
Tsukada, N., Kobata, T., Aizawa, Y., Yagita∥, H., & Okumura, K. (1999) · Blood · doi:10.1182/blood.v93.8.2738 · Cited by 144
Chêne, P., Fuchs, J. P., Bohn, J. A., Garcı́a-Echeverrı́a, C., Furet, P., & Fabbro, D. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.3738 · Cited by 139
Sun, H., Nikolovska‐Coleska, Z., Yang, C., Xu, L., Tomita, Y. A., Krajewski, K., Roller, P. P., & Wang, S. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0499108 · Cited by 134
ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-α
Künstle, G., Leist, M., Uhlig, S., Révész, L., Feifel, R., MacKenzie, A. R., & Wendel, A. (1997) · Immunology Letters · doi:10.1016/s0165-2478(96)02642-9 · Cited by 134
Wu, T. Y.-H., Wagner, K. W., Bursulaya, B. D., Schultz, P. G., & Deveraux, Q. L. (2003) · Chemistry & Biology · doi:10.1016/s1074-5521(03)00157-1 · Cited by 133
Kim, A. L., Raffo, A. J., Brandt‐Rauf, P. W., Pincus, M. R., Monaco, R. R., Abarzúa, P., & Fine, R. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34924 · Cited by 126
Milella, M., Estrov, Z. E., Kornblau, S. M., Carter, B. Z., Konopleva, M. Y., Tari, A. M., Schober, W. D., Harris, D., Leysath, C. E., Lopez‐Berestein, G., et al. (2002) · Blood · doi:10.1182/blood.v99.9.3461 · Cited by 119
Keith, F. J., Bradbury, D. A., Zhu, Y., & Russell, N. H. (1995) · PubMed · Cited by 117
Ku, G., Faust, T., Lauffer, L. L., Livingston, D. J., & Harding, M. W. (1996) · Cytokine · doi:10.1006/cyto.1996.0052 · Cited by 116
Disulfiram Is a Potent Inhibitor of Proteases of the Caspase Family
Nobel, S., Kimland, M., Nicholson, D. W., Orrenius, S., & Slater, A. F. G. (1997) · Chemical Research in Toxicology · doi:10.1021/tx970131m · Cited by 116
Roberts, D. L., Merrison, W., MacFarlane, M., & Cohen, G. M. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.1.221 · Cited by 116
Reactivation of Mutant p53 through Interaction of a C-Terminal Peptide with the Core Domain
Selivanova, G., Ryabchenko, L., Jansson, E., Iotsova, V., & Wiman, K. G. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3395 · Cited by 111
Natori, S., Higuchi, H., Contreras, P., & Gores, G. J. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50019 · Cited by 109
Choong, I., Lew, W., Lee, D. M., Pham, P., Burdett, M. T., Lam, J. W., Wiesmann, C., Luong, T. N., Fahr, B. J., DeLano, W. L., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020230j · Cited by 106
An, W. G., Schnur, R. C., Neckers, L., & Blagosklonny, M. V. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050626 · Cited by 104
Valentino, K. L., Gutierrez, M. E., Sanchez, R., Winship, M. J., & Shapiro, D. A. (2003) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp41441 · Cited by 101
Shangary, S. K., & Johnson, D. E. (2002) · Biochemistry · doi:10.1021/bi025605h · Cited by 100
Hoglen, N. C., Chen, L.-S., Fisher, C. D., Hirakawa, B. P., Groessl, T., & Contreras, P. C. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062034 · Cited by 97
Xie, X., Zhao, X., Liu, Y., Zhang, J., Matusik, R. J., Slawin, K. M., & Spencer, D. M. (2001) · PubMed · Cited by 94
Tetrocarcin A inhibits mitochondrial functions of Bcl-2 and suppresses its anti-apoptotic activity.
Nakashima, T., Miura, M., & Hara, M. (2000) · PubMed · Cited by 92
Cellular, Biochemical, and Genetic Analysis of Mechanism of Small Molecule IAP Inhibitors
Wang, Z., Cuddy, M., Samuel, T., Welsh, K., Schimmer, A. D., Hanaii, F., Houghten, R. A., Pinilla, C., & Reed, J. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405022200 · Cited by 90
Chapman, J. G., Magee, W. P., Stukenbrok, H., Beckius, G. E., Milici, A. J., & Tracey, W. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02484-6 · Cited by 85
Potential and caveats of TRAIL in cancer therapy
Held, J., & Schulze‐Osthoff, K. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0208 · Cited by 78
Self-citationKim, K. M., Giedt, C. D., Basáñez, G., O’Neill, J., Hill, J. J., Han, Y.-H., Tzung, S.-P., Zimmerberg, J. J., Hockenbery, D. M., & Zhang, K. Y. J. (2001) · Biochemistry · doi:10.1021/bi002368e · Cited by 78
Intracellular antibody-caspase-mediated cell killing: An approach for application in cancer therapy
Tse, E., & Rabbitts, T. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.12266 · Cited by 75
Jia, L., Zhang, L.-H., Yu, C.-J., Zhao, J., Xu, Y., Gui, J.-H., Jin, M., Ji, Z., Wen, W.-H., Wang, C.-J., et al. (2003) · PubMed · Cited by 69
Peptides Targeting Caspase Inhibitors
Tamm, I., Trepel, M., Cardó‐Vila, M., Sun, Y., Welsh, K., Cabezas, E., Swatterthwait, A., Arap, W., Reed, J. C., & Pasqualini, R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210133200 · Cited by 68
Schimmer, A. D., Hedley, D. W., Chow, S., Pham, N.-A., Chakrabartty, A., Bouchard, D., Mak, T. W., Trus, M., & Minden, M. D. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400870 · Cited by 59
Increased Fas antigen on T cells in multiple sclerosis
Ichikawa, H., Ota, K., & Iwata, M. (1996) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00149-x · Cited by 58
Eggermont, A. M. M., & ten Hagen, T. L. M. (2001) · Current Oncology Reports · doi:10.1007/s11912-001-0090-8 · Cited by 56
Toulmond, S., Tang, K., Bureau, Y. R. J., et al. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705662 · Cited by 56
Miller, B. E., Krasney, P. A., Gauvin, D. M., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.3.1331 · Cited by 53
Ablation of microvessels in vivo upon dimerization of iCaspase-9
Nör, J., Hu, Y., Song, W., Spencer, D. M., & Núñez, G. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301671 · Cited by 49
Maurici, D., Monti, P., Campomenosi, P., North, S., Frébourg, T., Fronza, G., & Hainaut, P. L. (2001) · Oncogene · doi:10.1038/sj.onc.1204428 · Cited by 49
OKAMOTO, Y., Anan, H., NAKAI, E., et al. (1999) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.47.11 · Cited by 46
Xu, Y., Wang, L., Jia, L., Qiu, X., Zhao, J., Yu, C.-J., Zhang, R., Zhu, F., Wang, C., Jin, B., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.61 · Cited by 43
Karanewsky, D. S., Bai, X., Linton, S. D., Krebs, J., Wu, J., Pham, B., & Tomaselli, K. J. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00498-3 · Cited by 42
Characterization of the Caspase Inhibitor IDN-1965 in a Model of Apoptosis-Associated Liver Injury
Hoglen, N. C., Hirakawa, B. P., Fisher, C. D., Weeks, S., Srinivasan, A. N., Wong, A. M., Valentino, K. L., Tomaselli, K. J., Bai, X., Karanewsky, D. S., et al. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29601-4 · Cited by 40
Identification of potent and novel small-Molecule inhibitors of caspase-3
Allen, D. A., Pham, P., Choong, I., Fahr, B. J., Burdett, M. T., Lew, W., DeLano, W. L., Gordon, E. M., Lam, J. W., O'Brien, T., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2003.08.024 · Cited by 27
Feng, W., Liu, F., Patwari, Y., Agrawal, S. G., Newland, A. C., & Jia, L. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04268.x · Cited by 26
Dipeptidyl aspartyl fluoromethylketones as potent caspase inhibitors: SAR of the N-protecting group
Cai, S. X., Guan, L., Jia, S., Wang, Y., Wu, Y., Tseng, B., & Drewe, J. A. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.08.027 · Cited by 26
Cited by
Redox regulation of cell survival
Trachootham, D., Lu, W., Ogasawara, M. A., Valle, N. R.-D., & Huang, P. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1957 · Cited by 1,781
Apoptosis: a basic biological phenomenon with wide‐ranging implications in human disease
FADEEL, B., & ORRENIUS, S. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01570.x · Cited by 698
Pharmacological Inhibitors of the NLRP3 Inflammasome
Zahid, A., Li, B., Kombe, A. J. K., Jin, T., & Tao, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02538 · Cited by 671
Anti‐cancer properties of anthraquinones from rhubarb
Huang, Q., Lu, G., Shen, H., Chung, M. C. M., & Ong, C. N. (2007) · Medicinal Research Reviews · doi:10.1002/med.20094 · Cited by 559
To kill a tumor cell: the potential of proapoptotic receptor agonists
Ashkenazi, A., & Herbst, R. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34359 · Cited by 323
Metadata
- Authors
- Fischer, U., & Schulze-Osthoff, K.
- Venue
- Cell Death & Differentiation
- Published
- 2005-01-21
- Volume
- 12
- Issue
- S1
- Pages
- 942-961
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W1975731421
- Cited by
- 282
- References
- 145
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.